The polynuclear CuII complexes [Cu4Cl2(bpy)4(PCh–)2](ClO4)4·H2O (1) and [Cu6(bpy)6(PMEAPy–)4](ClO4)8·2H2O (2), where bpy = 2,2′‐bipyridine, PCh– = phosphocholine {[2‐(phosphonooxy)ethyl]trimethylammonium} and PMEDAPy– = 1‐[2‐(phosphonomethoxy)ethyl]‐2,4‐diaminopyrimidine, have been synthesized and characterized by X‐ray single‐crystal analysis. Compound 1 crystallizes in the triclinic system (P‐1 space group) and consists of tetranuclear CuII units, which are threefoldly bridged by μ3‐O,O′,O″‐phosphate groups in a square arrangement around the copper atoms. Complex 2 crystallizes in the monoclinic system (P21/c space group) and consists of hexanuclear CuII units containing the same kind of μ3‐phosph(on)ate bridges like 1 and in addition μ4‐O,O′,O″,O″‐phosphonate bridges. The topology of compound 2 can be envisaged as two triangular subunits linked by means of a double Cu–O–Cu bridge provided by the μ4‐phosphonate unit. Magnetic susceptibility measurements of the two complexes in the temperature range of 2–300 K show weak antiferromagnetic couplings mediated by the phosph(on)ate bridges. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)